The epidermal growth factor receptor (EGFR) plays a pivotal role in the development and progression of solid tumors, making it a crucial therapeutic target in various cancer types, including non-small-cell lung carcinoma (NSCLC), breast cancer, gastroesophageal cancer and colorectal cancer [54]. This evidence concerns the gene EGFR and breast cancer.